Skip to main content
Clinical Trials/NCT05418933
NCT05418933
Unknown
N/A

Effects of Family Workshops on Children With Global Developmental Delays and Their Parents

Taipei Medical University1 site in 1 country101 target enrollmentJune 10, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Global Developmental Delay
Sponsor
Taipei Medical University
Enrollment
101
Locations
1
Primary Endpoint
Pediatric Outcome Data Collection Instrument
Last Updated
3 years ago

Overview

Brief Summary

To investigate the therapeutic effects of family workshops on children with global developmental delays and their parents by the analysis of the previously conducted workshops.

Detailed Description

To evaluate the effects of family workshops for children aged 18-36 months old with language developmental delays conducted from Jan 2014 Jan to Dec 2018, by the data analysis. The participants were children with global developmental delay (language delay with at least one delay in motor, cognitive function, or emotional and social functioning) and their parents in the workshops. The family workshops were conducted with 5 courses, with 6-7 families in one course, a 2-hour session per week, for 6 weeks. Effects: 1. Investigate the therapeutic effects of workshops for children with global developmental delays 2. Investigate the therapeutic effects of workshops for the parents of children with global developmental delays

Registry
clinicaltrials.gov
Start Date
June 10, 2022
End Date
August 1, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ru-Lan Hsieh

MD, Professor

Taipei Medical University

Eligibility Criteria

Inclusion Criteria

  • Children aged 18-36 months old with global developmental delays (language developmental delay, with motor, cognition, or social and emotional developmental delays) Parents and children attended the one 2 hour-session of workshop per week for 6 weeks

Exclusion Criteria

  • Less than 18 months old or older than 36 months old

Outcomes

Primary Outcomes

Pediatric Outcome Data Collection Instrument

Time Frame: scores change of Pediatric Outcome Data Collection Instrument from baseline to 6 weeks after treatment

measure the functional performance of children, the minimum and maximum values range from 1 to 100, higher scores mean a better outcome

Secondary Outcomes

  • Peabody Developmental Motor Scale(scores change of Peabody Developmental Motor Scale from baseline to 6 weeks after treatment)
  • Pediatric Daily Occupation Scale(scores change Pediatric Daily Occupation Scale from baseline to 6 weeks after treatment)
  • Pediatric Quality of Life Inventory-Geriatric Core Scale(scores change ofPediatric Quality of Life Inventory-Geriatric Core Scale from baseline to 6 weeks after treatment)
  • Pediatric Quality of Life Inventory-Family Impact Module(scores change of Pediatric Quality of Life Inventory-Family Impact Module from baseline to 6 weeks after treatment)
  • Caregiver Strain Index(scores change of Caregiver Strain Index from baseline to 6 weeks after treatment)
  • Emotional Competency Rating Scale(scores change of Emotional Competency Rating Scale from baseline to 6 weeks after treatment)
  • Mandarin-Chinese Communicative Developmental Inventory(percent change of Mandarin-Chinese Communicative Developmental Inventory from baseline to 6 weeks after treatment)
  • Parental satisfaction questionnaire(scores of Parental satisfaction questionnaire after treatment)
  • Pediatric Evaluation of Disability Inventory(scores change of Pediatric Evaluation of Disability Inventory from baseline to 6 weeks after treatment)

Study Sites (1)

Loading locations...

Similar Trials